CONCORD, Calif.--(BUSINESS WIRE)--

Cerus Corporation (NASDAQ: CERS) announced today that company management will present at the JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008 at 1:00pm EDT at Le Parker Meridien hotel in New York City.

A live webcast will be available via the Investors page of the company Web site at www.cerus.com. An archived presentation will be available on the Web site for seven days.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The Company is also pursuing regulatory approvals in the United States and other countries. The INTERCEPT red blood cell system is currently in clinical development. For more information on Cerus Corporation or the INTERCEPT Blood System visit www.cerus.com.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Source: Cerus Corporation